Home > PJ (current issue) > News / News Centre | Search

PJ Online homeThe Pharmaceutical Journal
Vol 274 No 7350 p601-606
21 May 2005

This section
Reprint   Photocopy

PDF 280K, Acrobat Reader

News summary

DIARY   Branch meetings   Future Events   Conferences

601 Clinical trial pharmacy services guidance launched New practice guidance on clinical trial pharmacy services was launched this week ...more

601 Section 60 Order consultation delayed again The timetable for the modernisation of the Royal Pharmaceutical Society’s regulatory processes has been put back for a fourth time ...more

601 AfC pay deadlines missed Only 21 per cent of NHS organisations had hit the Agenda for Change target of transferring at least half their staff onto the appropriate AfC payband by the end of April, Andrew Foster, director of workforce at the Department of Health, said at the NHS annual human resources conference last week ...more

601 Vote on new EU directive Last week, the European Parliament voted on a single directive to replace 15 directives that govern the recognition of professional qualifications across member states, including two that apply to pharmacy (85/432/EEC and 85/433/EEC) ...more

601 New contract VAT concerns VAT implications of the new contract arrangements were raised at the National Pharmaceutical Association’s board of management’s April meeting and at last week’s Pharmaceutical Services Negotiating Committee meeting ...more

601 PSNC contract roadshows Roadshows are to be organised later in the year by the Pharmaceutical Services Negotiating Committee to provide information and support to help contractors in England fully comply with the new community pharmacy contract services, the PSNC’s chief executive Sue Sharpe said at a press briefing following last week’s committee meeting ...more

602 NHS stop-smoking services success rate increased The number of people who have quit smoking with the help of NHS stop-smoking services has increased by almost 50 per cent in one year, according to provisional Government figures ...more

602 Health responsibilities reconfigured as new minister given pharmacy Jane Kennedy, the newly appointed Minister of State for quality and patient safety has been given the pharmacy portfolio previously assigned to Rosie Winterton ...more

602 Easier access to negligence compensation announced Victims of clinical negligence in the NHS are to get access to a new scheme for redress ...more

602 £140,000 made available for research on the new contract The Pharmacy Practice Research Trust, which is supported by the Royal Pharmaceutical Society, is offering up to £140,000 to fund a research project exploring the implementation of the new contractual frameworks for community pharmacy ...more

603 PCTs see pharmacies as businesses, NAO concludes Primary care trusts prefer to view community pharmacies as businesses, rather than primary care providers, when considering NHS local improvement finance trust (LIFT) schemes ...more

603 Weight gain counters benefits of quitting smoking on lung function Preventing weight gain after smoking cessation could maximise the beneficial effects of quitting on lung function, according to a study published this month ...more

603 UniChem launches guide to advanced services UniChem is launching its second “Solutions” guide, to help pharmacy contractors meet the requirements of advanced services under the new community pharmacy contract ...more

603 Locums can earn loyalty points with agency A loyalty points system for locums has been launched by Healthcare Locums ...more

603 New SPGC website The Scottish Pharmaceutical General Council has relaunched its website ...more

603 Prescription charge refunds The Scottish Pharmaceutical General Council wrote to community pharmacists this week to clarify that pharmacies in Scotland do not have to give prescription charge refunds ...more

603 Indemnity policy for technicians Professional indemnity insurance is being offered to pharmacy technicians and accuracy checking dispensary assistants by NPA subsidiary Pharmacists Professional Indemnity Ltd ...more

604 Contraceptive advice may confuse New guidance on the advice that health professionals should give to women who have missed some of their oral contraceptive pills may be confusing, claim the authors of a comment published in The Lancet this week ...more

604 Is EHC reaching those women most at risk? More research is needed into whether new routes of supply of emergency hormonal contraception are appropriate for younger women and those from lower socio-economic groups, researchers say ...more

604 LCD drug pack wins award A tablet or capsule pack with an LCD screen, showing patients how to take their medicine, has won James Barber, University of Leeds, a design award sponsored by Almus ...more

604 UK mumps epidemic threat Cases of mumps in England and Wales increased dramatically last year, the Health Protection Agency has announced ...more

604 CSM warning on atypical antipsychotics not heeded Risperidone (Risperdal) and olanzapine (Zyprexa) are still being prescribed to a large proportion of people with dementia, according to the Alzheimer’s Society, despite Committee on Safety of Medicines advice that they should not be used for this indication ...more

604 Bleeding risk offsets aspirin benefit in healthy over-70s Benefits of low-dose aspirin on the risk of cardiovascular disease in patients aged 70 years or over who do not have overt cardiovascular disease are offset by increases in bleeding, a study published online has shown ...more

604 Vitamin E may protect against Parkinson’s disease Dietary vitamin E may protect against the development of Parkinson’s disease, a meta-analysis of eight studies of dietary vitamin intake has shown ...more

605 Trastuzumab halves the risk of recurrence in early breast cancer The HER2-receptor blocker trastuzumab (Herceptin) reduces the risk of recurrence by 46 per cent in women with early-stage breast cancer expressing HER2, according to results from the international HERA (Herceptin adjuvant) study, which specialists agreed would change practice ...more

605 Angiogenesis inhibitor extends survival in lung cancer and advanced breast cancer The angiogenesis inhibitor bevacizumab (rhuMAb-VEGF; Avastin) extends survival in patients with non-small cell lung cancer (NSCLC) and in women with advanced breast cancer, according to studies reported this week at the American Society of Clinical Oncology annual meeting ...more

605 Chemotherapy improves survival in operable GI cancer Giving chemotherapy before and after surgery improves survival in patients with operable gastric and lower oesophageal cancers, according to a Medical Research Council study presented at the American Society of Clinical Oncology annual meeting this week ...more

605 Doxorubicin-docetaxel toxicity stops breast cancer trial early Combination therapy with doxorubicin and docetaxel for breast cancer was associated with a high risk of life-threatening complications and led to premature termination of a trial involving 627 women ...more

605 Letrozole improves survival Letrozole (Femara) offers a survival benefit over tamoxifen in hormone-sensitive early breast cancer ...more

605 Rituximab maintenance therapy Maintenance therapy with rituximab (MabThera) in patients with follicular non-Hodgkin’s and mantle cell lymphoma who were initially treated with rituximab and chemotherapy almost doubled time to relapse, new data suggest ...more

606 Statins cost-effective for wider range of people Statin therapy may be cost-effective in a wider range of people than was previously thought, new data suggest ...more

606 Isotretinoin does not increase depression Treating adolescents who have moderate to severe acne with isotretinoin (Roaccutane) does not increase symptoms of depression, a new study suggests ...more

606 Paediatric trials network A network that supports research into children’s medicines has been launched ...more

606 Split paracetamol suppositories Researchers show that paracetamol is uniformly distributed in suppositories. However, when anaesthetists split them (to achieve doses for children) a wide range of doses were recorded ...more

Back to Top


©The Pharmaceutical Journal